fibrodysplasia ossificans progressiva

Search with Google Search with Bing
Information
Disease name
fibrodysplasia ossificans progressiva
Disease ID
DOID:13374
Description
"A connective tissue disease that is characterized by progressive ossification of skeletal muscle, fascia, tendons, and ligaments and has_material_basis_in heterozygous mutation in the ACVR1 gene." [url:http\://en.wikipedia.org/wiki/Fibrodysplasia_ossificans_progressiva, url:http\://ghr.nlm.nih.gov/condition/fibrodysplasia-ossificans-progressiva, url:http\://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424023/, url:https\://www.ucsfbenioffchildrens.org/conditions/fibrodysplasia-ossificans-progressiva]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04818398 Completed Phase 1 Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects April 1, 2021 July 26, 2022
NCT02190747 Completed Phase 2 An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects July 14, 2014 May 23, 2016
NCT02279095 Completed Phase 2 An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP) October 9, 2014 September 20, 2022
NCT02322255 Completed A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP) December 18, 2014 April 9, 2020
NCT02066324 Completed Urine Sample Collection From FOP Patients November 2013 August 2014
NCT03188666 Completed Phase 2 A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva February 26, 2018 September 16, 2021
NCT03312634 Completed Phase 3 An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva. November 30, 2017 September 7, 2022
NCT04829773 Completed Phase 1 Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects January 3, 2019 March 29, 2019
NCT04665323 Completed An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families. January 18, 2021 April 30, 2021
NCT06089616 Not yet recruiting A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP) April 15, 2024 January 31, 2034
NCT04307953 Recruiting Phase 2 Saracatinib Trial TO Prevent FOP August 5, 2020 May 6, 2025
NCT05039515 Recruiting Phase 2 A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). December 1, 2021 August 30, 2029
NCT05394116 Recruiting Phase 3 A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP) November 21, 2022 June 12, 2026
NCT02521792 Terminated Phase 2 In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects December 7, 2015 August 4, 2016
Disase is a (Disease Ontology)
DOID:65
Cross Reference ID (Disease Ontology)
GARD:6445
Cross Reference ID (Disease Ontology)
ICD10CM:M61.1
Cross Reference ID (Disease Ontology)
ICD9CM:728.11
Cross Reference ID (Disease Ontology)
MESH:D009221
Cross Reference ID (Disease Ontology)
MIM:135100
Cross Reference ID (Disease Ontology)
NCI:C3040
Cross Reference ID (Disease Ontology)
ORDO:337
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:82725007
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0016037
Exact Synonym (Disease Ontology)
myositis ossificans progressiva
Exact Synonym (Disease Ontology)
progressive myositis ossificans
Exact Synonym (Disease Ontology)
progressive ossifying myositis
Exact Synonym (Disease Ontology)
Stone Man Syndrome
OrphaNumber from OrphaNet (Orphanet)
337